康缘药业
(600557)
| 流通市值：69.01亿 | | | 总市值：69.01亿 |
| 流通股本：5.66亿 | | | 总股本：5.66亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,956,802,757.98 | 2,035,973,677.98 | 2,148,110,744.09 | 2,157,376,554.5 |
| 应收票据及应收账款 | 517,316,921.19 | 488,146,755.24 | 464,942,071.53 | 487,831,564.21 |
| 应收账款 | 517,316,921.19 | 488,146,755.24 | 464,942,071.53 | 487,831,564.21 |
| 应收款项融资 | 220,375,743.76 | 135,610,386.55 | 134,648,501.11 | 143,074,828.53 |
| 预付款项 | 31,097,097.71 | 29,298,155.21 | 50,405,033.06 | 20,914,537.11 |
| 其他应收款合计 | 14,695,879.03 | 7,499,309.71 | 11,574,176.44 | 3,298,830.7 |
| 存货 | 406,297,457.22 | 457,596,790.84 | 452,563,993.85 | 445,231,555.04 |
| 其他流动资产 | 46,064,672.51 | 52,279,193.91 | 50,873,060.4 | 43,905,538.38 |
| 流动资产合计 | 3,192,650,529.4 | 3,206,404,269.44 | 3,313,117,580.48 | 3,301,633,408.47 |
| 非流动资产: | | | | |
| 长期股权投资 | 4,146,002.75 | 4,136,956.24 | 4,136,956.24 | 4,136,930.02 |
| 其他非流动金融资产 | - | - | 6,966,154.96 | 7,195,658.61 |
| 固定资产 | 2,704,755,204.69 | 2,411,952,826.77 | 2,458,834,994.51 | 2,195,180,961.17 |
| 在建工程 | 411,187,612.99 | 587,140,077.2 | 438,977,361.85 | 694,601,898.81 |
| 使用权资产 | 1,031,195.08 | 1,097,016.05 | 1,162,837.01 | 1,228,657.98 |
| 无形资产 | 385,990,332.52 | 235,679,242.26 | 239,070,608.07 | 203,624,875.41 |
| 开发支出 | 55,175,383.57 | 165,289,250.09 | 164,506,928.08 | 190,945,395.7 |
| 商誉 | 58,988,858.14 | 58,988,858.14 | 58,988,858.14 | 58,988,858.14 |
| 长期待摊费用 | 43,979,126.82 | 47,471,477.14 | 51,035,326.95 | 12,013,718.05 |
| 递延所得税资产 | 47,963,977.9 | 46,883,060.94 | 45,127,825.62 | 47,707,328.69 |
| 其他非流动资产 | 65,688,027.24 | 121,995,443.1 | 80,670,333.6 | 22,992,658.5 |
| 非流动资产合计 | 3,778,905,721.7 | 3,680,634,207.93 | 3,549,478,185.03 | 3,438,616,941.08 |
| 资产总计 | 6,971,556,251.1 | 6,887,038,477.37 | 6,862,595,765.51 | 6,740,250,349.55 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 251,332,372.05 | 236,747,495.85 | 226,387,681.94 | 210,331,077.22 |
| 其中：应付票据 | 32,302,898.41 | - | - | 42,971,261.41 |
| 应付账款 | 219,029,473.64 | 236,747,495.85 | 226,387,681.94 | 167,359,815.81 |
| 合同负债 | 19,236,743.22 | 30,981,491.97 | 27,739,017.34 | 22,825,314 |
| 应付职工薪酬 | 21,173,268.53 | 14,023,593.4 | 27,158,114.07 | 20,321,249.96 |
| 应交税费 | 51,683,389.16 | 29,125,476.27 | 46,666,067.12 | 60,648,149.02 |
| 其他应付款合计 | 1,319,544,165.72 | 1,342,797,654.99 | 1,390,004,268.49 | 1,334,835,769.66 |
| 应付股利 | 4,719,600 | - | - | - |
| 一年内到期的非流动负债 | 254,820.78 | 252,647.71 | 250,499.71 | 248,351.71 |
| 其他流动负债 | 1,862,331 | 3,389,148.34 | 2,967,626.63 | 2,967,290.83 |
| 流动负债合计 | 1,665,087,090.46 | 1,657,317,508.53 | 1,721,173,275.3 | 1,652,177,202.4 |
| 非流动负债: | | | | |
| 租赁负债 | 536,709.94 | 812,248 | 805,342.24 | 798,436.48 |
| 长期应付款 | - | - | - | 1,925,490 |
| 递延收益 | 145,380,158.73 | 136,358,465.88 | 128,222,043.83 | 172,561,838.71 |
| 非流动负债合计 | 145,916,868.67 | 137,170,713.88 | 129,027,386.07 | 175,285,765.19 |
| 负债合计 | 1,811,003,959.13 | 1,794,488,222.41 | 1,850,200,661.37 | 1,827,462,967.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 566,158,806 | 566,158,806 | 566,158,806 | 566,158,806 |
| 盈余公积 | 36,044,796.01 | 36,044,796.01 | 36,044,796.01 | - |
| 未分配利润 | 4,363,460,805.34 | 4,295,578,978.32 | 4,216,303,030.41 | 4,148,058,755.42 |
| 归属于母公司股东权益合计 | 4,965,664,407.35 | 4,897,782,580.33 | 4,818,506,632.42 | 4,714,217,561.42 |
| 少数股东权益 | 194,887,884.62 | 194,767,674.63 | 193,888,471.72 | 198,569,820.54 |
| 股东权益合计 | 5,160,552,291.97 | 5,092,550,254.96 | 5,012,395,104.14 | 4,912,787,381.96 |
| 负债和股东权益合计 | 6,971,556,251.1 | 6,887,038,477.37 | 6,862,595,765.51 | 6,740,250,349.55 |
| 公告日期 | 2026-08-28 | 2026-04-30 | 2026-04-23 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |